EUROFINS DISCOVERX LLC
- FREMONT, CA 94538-6563
- discoverx.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $17.7K
- Awards on record
- 4
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
EUROFINS DISCOVERX LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About EUROFINS DISCOVERX LLC
- Headquarters
- FREMONT, CA 94538-6563
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIHANEMEJA2KD7
- CAGE47WF5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $17.7K
- Awards on record
- 4
- Top funding agencies
- Department of Veterans Affairs
Awards
36C26224P0836
Completed: Period of performance ended Feb 28, 2025EUROFINS PANELING SERVICE
Department of Veterans Affairs
- Obligated
- $17.7K
- Period of performance
- Mar 1, 2024 – Feb 28, 2025
75N95021P00604
Completed: Period of performance ended Sep 17, 2022TESTING COMPOUNDS
Department of Health and Human Services · National Institutes of Health
- Obligated
- $24.3K
- Period of performance
- Sep 17, 2021 – Sep 17, 2022
75N95020P00618
Completed: Period of performance ended Sep 15, 2021TESTING OF 30 COMPOUNDS FOR IRAK AND FLT3 KINASE BINDING; PERIOD OF PERFORMANCE SEPTEMBER 16, 2020 - SEPTEMBER 15, 2021
Department of Health and Human Services · National Institutes of Health
- Obligated
- $20.8K
- Period of performance
- Sep 16, 2020 – Sep 15, 2021
75N95020P00400
Completed: Period of performance ended Dec 31, 2020KINASE PANEL SCREENING OF 25 SMALL MOLECULES; PERIOD OF PERFORMANCE AUGUST 7, 2020 - DECEMBER 31, 2020
Department of Health and Human Services · National Institutes of Health
- Obligated
- $22.9K
- Period of performance
- Aug 7, 2020 – Dec 31, 2020
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C26224P0836 EUROFINS PANELING SERVICE | Department of Veterans Affairs | 541380 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $17.7K | Mar 1, 2024 – Feb 28, 2025 | Completed: Period of performance ended Feb 28, 2025 |
75N95021P00604 TESTING COMPOUNDS | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $24.3K | Sep 17, 2021 – Sep 17, 2022 | Completed: Period of performance ended Sep 17, 2022 |
75N95020P00618 TESTING OF 30 COMPOUNDS FOR IRAK AND FLT3 KINASE BINDING; PERIOD OF PERFORMANCE SEPTEMBER 16, 2020 - SEPTEMBER 15, 2021 | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $20.8K | Sep 16, 2020 – Sep 15, 2021 | Completed: Period of performance ended Sep 15, 2021 |
75N95020P00400 KINASE PANEL SCREENING OF 25 SMALL MOLECULES; PERIOD OF PERFORMANCE AUGUST 7, 2020 - DECEMBER 31, 2020 | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $22.9K | Aug 7, 2020 – Dec 31, 2020 | Completed: Period of performance ended Dec 31, 2020 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 15 awards
- Total awarded
- $3,979,168
- By phase
- SBIR Phase I: 12
- SBIR Phase II: 3
- By agency
- Department of Health and Human Services: 15
- By year
- 2007: 2
- 2006: 1
- 2005: 1
- 2004: 2
- 2003: 4
- 2002: 3
- 2001: 1
- 2000: 1
Awards (most recent first)
Development of an EFC Assay to Measure Growth Factor Receptor Dimer Formation for
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $113,104
Solicitation year 2007
EFC assay to measure Allosteric Regulation of Protein Kinases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $115,923
Solicitation year 2007
Novel Drug Screening Assays for Orphan GPCRs
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $151,179
Solicitation PHS2006-2 (2006)
Nuclear Transcription Factor Translocation Assay
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2005 · $800,943
Solicitation PHS2005-2 (2005)
EFC Assay to Measure Growth Factor Receptors
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $131,396
Solicitation PHS2004-2 (2004)
Trafficking of Channels Measured by EFC
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $136,395
Solicitation PHS2004-2 (2004)
Cell Based EFC Assay for Protease Drug Discovery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $122,000
Nuclear Transcription Factor Translocation Assay
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000
Complementation Assay for GPCR Desensitization
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $150,249
COMPLEMENTATION ASSAY TO SCREEN FOR KINASE INHIBITORS
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2003 · $750,000
COMPLEMENTATION ASSAY FOR PROTEIN KINASE INHIBITORS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $84,682
COMPLEMENTATION ASSAY FOR G PROTEIN LINKED RECEPTORS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2002 · $0
COMPLEMENTATION ASSAY FOR G PROTEIN LINKED RECEPTORS
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2002 · $1,098,297
COMPLEMENTATION ASSAY FOR FUNCTIONAL GENOMICS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2001 · $120,000
Not Available
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2000 · $105,000
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
- 541713Research and Development in NanotechnologySmall business under this code’s size standard
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Small business under this code’s size standard
SAM.gov reports this entity as small under 2 of 3 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- 6505DRUGS AND BIOLOGICALS
- AJ14GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES
- AJ15GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D FACILITIES & MAJ EQUIP
- AK14GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES
- AN14HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES
- AN21HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; BASIC RESEARCH
- AN22HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
- AN23HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; EXPERIMENTAL DEVELOPMENT
- AN24HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; R&D ADMINISTRATIVE EXPENSES
- AN31HEALTH R&D SERVICES; CONSUMER AND OCCUPATIONAL HEALTH AND SAFETY; BASIC RESEARCH
- AN32HEALTH R&D SERVICES; CONSUMER AND OCCUPATIONAL HEALTH AND SAFETY; APPLIED RESEARCH
- AN33HEALTH R&D SERVICES; CONSUMER AND OCCUPATIONAL HEALTH AND SAFETY; EXPERIMENTAL DEVELOPMENT
- AN34HEALTH R&D SERVICES; CONSUMER AND OCCUPATIONAL HEALTH AND SAFETY; R&D ADMINISTRATIVE EXPENSES
- AN44HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with EUROFINS DISCOVERX LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
